-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense Therapeutics Announces Annual General Meeting of Shareholders

PUBT·11/18/2026 21:03:47
Listen to the news
NeuroSense Therapeutics Announces Annual General Meeting of Shareholders
  • NeuroSense Therapeutics will hold its annual general meeting in Ra'anana, Israel, on December 29, 2026.
  • Shareholders will consider authorizing reverse share splits at an aggregate ratio of 1-for-2 to 1-for-20 within 12 months of the meeting.
  • The authorization would replace the remaining reverse share split authority approved on August 26, 2026, rather than supplement it.
  • Authorized ordinary shares would remain at 200 million, increasing available issuance capacity relative to outstanding shares.
  • Other proposals cover director re-elections, three-year compensation policy renewal and Somekh Chaikin's appointment as auditor for 2026 through the next annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-121806), on November 18, 2026, and is solely responsible for the information contained therein.